![]() |
Volumn 121, Issue 6, 2002, Pages 1733-1735
|
Challenges of treating latent tuberculosis infection
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ISONIAZID;
PYRAZINAMIDE;
RIFAMPICIN;
COST BENEFIT ANALYSIS;
DRUG EFFICACY;
DRUG SAFETY;
EDITORIAL;
HEALTH CARE;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
INFECTION;
PRIORITY JOURNAL;
RISK FACTOR;
SCREENING;
SOCIAL SUPPORT;
TUBERCULIN TEST;
TUBERCULOSIS;
|
EID: 0036282637
PISSN: 00123692
EISSN: None
Source Type: Journal
DOI: 10.1378/chest.121.6.1733 Document Type: Editorial |
Times cited : (4)
|
References (15)
|